As controlled release drug delivery systems continue to play an important role among the emerging areas of research in the treatment of diseases, this event will focus on specific topics looking at advances made in the field and how to overcome the challenges involved when developing controlled release formulations.

Returning for its twelfth year and following on from the major success of previous events, SMi are proud to present the 12th annual Controlled Release Conference, 20th - 21st April 2015, London, UK.
Through a series of interactive presentations and panel discussions, the goal of this major networking event is to spotlight principles and illustrative examples facilitating access to the findings of industry innovators on current activities and trends. Ultimately serving as a valuable resource for capturing the ‘big picture’ of the latest research and developments, this is a must attend event!

Key topics include:

• Ocular treatment - beating the challenge of systemic long term delivery in the eye
• Delivery of therapeutic antibodies… overcoming the technical challenges to add value to the patient whilst ensuring efficacy and stability of the drug
• Use of solid dispersions to increase the solubility of drugs in terms of controlled release and assimilation
• Alternative Pathways for controlled release delivery
• Controlled release in animal health, challenges for testing

And much more!

This two day networking event will review the recent advances in the art and science of controlled release technology and to assess the prospects and directions of future developments. Join us and gain in depth knowledge by:-

• Gather insights into the latest technologies and methods in drug release mechanisms
• Spotlight on innovations in oral drug delivery systems
• Hearing cutting edge presentations from key players in the controlled release development arena
• Network with your peers and build lasting relationships

You should attend this event if you are a Director, Area head, Chief Executive, CSO, or Vice President within the pharmaceutical or healthcare industry with responsibilities in the following areas:

Drug Delivery
Drug Development
Business Development
Product Development
Research & Development
Global Alliances
Technical Sciences / Design


3m Healthcare; Boehringer Ingelheim Pharma GmbH & Co. KG; Callum Consultancy ; Ceylon Petroleum Corporation; Critical Pharmaceuticals Limited; Evonik; Faculty Of Pharmacy University Lisbon; Ferring; GlaxoSmithKline; GlaxoSmithKline Research & Development; Hoffmann-La Roche Inc; Imperial College London; Instituto de Engenharia Biomedica; IPSEN; Ipsen Research Laboratories; Italfarmaco; Kings College London; Kingston University; McNeil Consumer Specialty and Pharmaceuticals; MHRA; Novartis Pharmaceuticals; P C A S; Pharmacircle; Reading University; SiTec PharmaBio; University Of Greenwich; University Of Lisbon Faculty Of Pharmacy; University of Nottingham; University Of Porto; University of Reading; University Of Strathclyde; Weill Cornell Medical College in Qatar;

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Howard Stevens

Howard Stevens, Emeritus Professor, University Of Strathclyde

9:10 Sustained ocular drug release.... beating the challenges of long term delivery of biologics to the eye

Ian Catchpole

Ian Catchpole, Senior Investigator Senior Investigator BioPharm Innovation, GlaxoSmithKline

9:50 Overcoming the impact of patient factors in oral drug delivery

Howard Stevens

Howard Stevens, Emeritus Professor, University Of Strathclyde

10:30 Morning Coffee

11:00 Circadian drug delivery: Chronocort® a case study

Daniel Margetson

Daniel Margetson, Director CMC, Diurnal

• Understanding patient needs and identifying appropriate drug delivery solutions
• Developing innovative modified release drug therapies
• Successful product development for rare and orphan diseases

11:40 The selection and development of oral drug delivery technologies: GSK’s experiences and perspectives

Mark Wilson

Mark Wilson, Director, Collaboration Management, Europe, Platform Technology and Science, GlaxoSmithKline

• The nature of GSK’s drug delivery technology activities
• GSK’s extensive in-house development programme
• Developing partnerships with technology providers
• Using an open approach to source solutions and resolving practical collaboration challenges
• Managing the commercialisation and scale-up of technologies

12:20 Networking Lunch

13:20 Oral delivery of proteins and peptides: future prospects

Stephen Timothy  Buckley

Stephen Timothy Buckley, Senior Research Scientist, ADME, Novo Nordisk A/S

14:00 Opportunities and challenges in the development of controlled release systems for therapeutic antibodies

Daniel Schweizer

Daniel Schweizer, Functional Lead, Technical Research & Development, Biologics Process R&D, Pharmaceutical Development, Novartis Pharmaceuticals

• Local delivery of therapeutic antibodies is characterized by short drug residence times and a low compliance of administration
• Analysing why controlled release systems are options to enable and improve local delivery applications for antibodies
• Understanding how such systems can improve efficacy-dosing ratios and reduce treatment associated side effects
• Describing the general requirements of formulations for local delivery and controlled release for antibody drugs
• Discussing unresolved technical challenges in the development of such systems
• case study:  providing an in depth investigation and “lessons learned” of a hydrogel-based drug delivery system for therapeutic antibodies

14:40 Afternoon Tea

15:10 How can drug half-life extension improve patient care … the science behind albumin engineering to improve drug efficacy and tolerability

Darrell  Sleep

Darrell Sleep, Director, Biopharma R&D, Novozymes Biopharma UK Ltd

• Short circulatory half-life represents a major obstacle for many protein and peptide-based therapeutic agents, resulting in increased dosing with the consequent risk of side effects and reduced patient compliance
• The pharmacokinetics of peptides and proteins can be significantly improved by conjugation, association or fusion to albumin.  This extended circulatory half-life derives from both the size of albumin and recycling of the molecule via the neonatal Fc receptor, FcRn
• Human serum albumin has been modified to enhance its affinity for human FcRn.  This increase in affinity for the FcRn receptor translates to improved pharmacokinetic properties of the albumin molecule and ultimately the therapeutic candidate that is fused or conjugated to it
• The application of these novel albumin variants to improve the pharmacokinetic properties of a number of therapeutic candidates will be discussed

15:50 Use of solid dispersions to increase the solubility of drugs in terms of controlled release and assimilation

Teofilo Vasconcelos

Teofilo Vasconcelos, Senior Formulation Scientist Pharmaceutical Development, Bial

• Discussing  how solid dispersions can be used to enhance the dissolution rate of poorly water-soluble drugs and sustain drug release by choosing an appropriate carrier
• Understanding how the development of controlled release solid dispersion is advantageous for bypassing the risk of a ‘burst release’ of the drug
• Overview of recent technological advances for overcoming existing limitations
• Reviewing the different carriers being used for the preparation of controlled release solid dispersion

16:30 Capturing prior knowledge in formulation platforms to facilitate and rationalize decision-making. How do modified release formulations fit into a platform applicable to a broader range of APIs?

Morten Allesø

Morten Allesø, Principal Pharmaceutical Researcher, Biologics and Pharmaceutical Science, H. Lundbeck A/S

• Working with prior knowledge in the context of the ICH Q8/Q9 guidelines
• Introducing the platform concept using an immediate release formulation as example
• Extending the platform to include HPMC matrix formulations (case study)

17:10 Chairman’s Closing Remarks and Close of Day One

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Ian Catchpole

Ian Catchpole, Senior Investigator Senior Investigator BioPharm Innovation, GlaxoSmithKline

9:10 Novel drug delivery technologies for biomedical applications

Helder Santos

Helder Santos, Head of the Pharmaceutical Nanotechnology and Chemical Microsystems (NAMI) Unit, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy,, University Of Helsinki

• Novel delivery system technologies to achieve more uniform drug effects and better bioavailability
• Improving the drug dissolution and bioavailability of conventional drug molecules
• Nanomedicies for drug delivery and cancer targeting

9:50 Oral Peptide Delivery Landscape

Andy Lewis

Andy Lewis, Director Novel Formulation Technologies, Ipsen

• Biopharmaceutical considerations in developing oral peptide formulations
• Candidate selection for oral peptide formulations
• State of the art in oral peptide delivery and future prospects

10:30 Morning Coffee

11:00 Oral inhalation – it’s not just for pulmonary disease anymore

Kelly S Kraft

Kelly S Kraft, Director of Pharmaceutical Research, Mannkind Corporation

• Oral inhalation for systemic drug delivery
• Engineered particles and simple device combinations
• Advantages and challenges of drug delivery by oral inhalation
• Case studies in diabetes, pain and migraine

11:40 Investigation of parenteral depots: composition, dynamic structure and in vitro release

Michael Keller

Michael Keller, Senior Fellow, Technical R&D, Novartis Pharma AG

• Application of novel analytical techniques
• Relation of physicochemical characteristics with in vitro release
• QC of excipients as key factor for stability and in vitro release kinetics

12:20 Networking Lunch

13:20 Dissolution behavior and test methods of orally inhaled products

Sabine May

Sabine May, Scientific Assistant, Boehringer Ingelheim Pharma GmbH & Co. KG

• Dose collection method
• Evaluation of dissolution test methods
• Theoretical model calculation

14:00 A new three-dimensional cell-based intestinal in vitro model to explore intestinal absorption

Bruno Sarmento

Bruno Sarmento, Affiliated Researcher /Assistant Professor, INEB – Institute of Biomedical Engineering, University of Porto / Instituto Superior de Ciências da Saúde-Norte

• 3D  culture  models  encompass  a great  potential  to  build  up  a  bridge  between  the  cell  culture  models  and  in vivo animal models
• A triple co-culture comprising Caco-2, HT29-MTX and Raji B cells was set up to mimic in a closely way the human intestinal epithelium
• The formation of M-cells phenotype from enterocytes was identified for the first time in a co-culture system comprising Caco-2 and HT29-MTX cells
• Further improvement of the model was successfully established laying intestinal myofibroblasts under epithelial membrane reproducing somewhat the native intestinal mucosa in which stromal cells play a pivotal role in the establishment of intestinal architecture
• The present 3D model has potential to be routinely adopted as a platform for high-throughput analysis of drug absorption and diagnostic of intestinal diseases.

14:40 Afternoon Tea

15:10 Controlled Release in animal health

Martin Folger

Martin Folger , Head, Pharmaceutical Development, Boehringer Ingelheim Vetmedica GmbH

• Why controlled release in animal health
• Species aspects, food-producing animals vs. companion Animals
• Product examples
• Challenges for testing

15:50 Continuous manufacturing of pharmaceutical cocrystal by using hot melt extrusion

Dennis douroumis

Dennis douroumis, Assistant Professor, Faculty of Engineering and Sciences, , Faculty of Engineering and Sciences, University Of Greenwich

• Continuous cocrystallisation of water insoluble drugs
• Effect of process variables on the cocrystal’s quality
• Process analytical tools for quality control and process understanding
• Scale- up of extrusion cocrystallisation

16:30 Chairman’s Closing Remarks and Close of Day Two



Daniel Schweizer

Daniel Schweizer

Functional Lead, Technical Research & Development, Biologics Process R&D, Pharmaceutical Development, Novartis Pharmaceuticals
Howard Stevens

Howard Stevens

Emeritus Professor, University Of Strathclyde
Ian Catchpole

Ian Catchpole

Senior Investigator Senior Investigator BioPharm Innovation, GlaxoSmithKline

Andy Lewis

Director Novel Formulation Technologies, Ipsen
Andy Lewis

Bruno Sarmento

Affiliated Researcher /Assistant Professor, INEB – Institute of Biomedical Engineering, University of Porto / Instituto Superior de Ciências da Saúde-Norte
Bruno Sarmento

Daniel Margetson

Director CMC, Diurnal
Daniel Margetson

Daniel Schweizer

Functional Lead, Technical Research & Development, Biologics Process R&D, Pharmaceutical Development, Novartis Pharmaceuticals
Daniel Schweizer

Darrell Sleep

Director, Biopharma R&D, Novozymes Biopharma UK Ltd
Darrell  Sleep

Dennis douroumis

Assistant Professor, Faculty of Engineering and Sciences, , Faculty of Engineering and Sciences, University Of Greenwich
Dennis douroumis

Helder Santos

Head of the Pharmaceutical Nanotechnology and Chemical Microsystems (NAMI) Unit, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy,, University Of Helsinki
Helder Santos

Howard Stevens

Emeritus Professor, University Of Strathclyde
Howard Stevens

Ian Catchpole

Senior Investigator Senior Investigator BioPharm Innovation, GlaxoSmithKline
Ian Catchpole

Kelly S Kraft

Director of Pharmaceutical Research, Mannkind Corporation
Kelly S Kraft

Mark Wilson

Director, Collaboration Management, Europe, Platform Technology and Science, GlaxoSmithKline
Mark Wilson

Martin Folger

Head, Pharmaceutical Development, Boehringer Ingelheim Vetmedica GmbH
Martin Folger

Michael Keller

Senior Fellow, Technical R&D, Novartis Pharma AG
Michael Keller

Morten Allesø

Principal Pharmaceutical Researcher, Biologics and Pharmaceutical Science, H. Lundbeck A/S
Morten Allesø

Sabine May

Scientific Assistant, Boehringer Ingelheim Pharma GmbH & Co. KG
Sabine May

Stephen Timothy Buckley

Senior Research Scientist, ADME, Novo Nordisk A/S
Stephen Timothy  Buckley

Teofilo Vasconcelos

Senior Formulation Scientist Pharmaceutical Development, Bial
Teofilo Vasconcelos

Official Online Media Partners


Controlled Release Speaker Interview with GSK


Controlled Release Speaker Interview with Janssen


Media Partners

ONdrugDelivery Magazine

Official Online Media Partners

ONdrugDelivery Magazine is the highly regarded, world-leading series of sponsored themed drug delivery publications. Uniquely, each issue focuses tightly on one topic within the field of drug delivery. With a truly global readership already in excess of 40,000, and with contributions and loyal support from many of the most important companies in the drug delivery business - from among the largest to the smallest - ONdrugDelivery Magazine is a must for those in the industry who need to know what's going on in drug delivery.

Media Partners

Drug Patent Watch


DrugPatentWatch incorporates many data sources updated as frequently as possible, providing you with fresh information. The core data are updated monthly, using feeds directly from the FDA and USPTO. Sales information is updated annually. The accessory data – such as tentative approvals, US patent details, international patent information, etc – is updated weekly. Clinical trial and Paragraph IV data are updated daily. Annual editions — available in the Premium and Ultimate plans — provide historic archives of the state of drug patent expirations in each recorded year.

Medical News Today


Medical News Today is the largest independent medical and health news site on the web - with over 10,000,000 monthly unique users it is ranked number one for medical news on all major search engines. Medical News Today is used by pharmaceutical, biotech and health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted campaigns to HCPs, patients and caregivers. To find out how Medical News Today can help you to reach the right audience contact peter@medicalnewstoday.com or visit www.medicalnewstoday.com.

Select Science


SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover impartial, expert opinion and trusted reviews about latest laboratory equipment and techniques; plus videos, application notes and science news from around the world. Become a member for free today.



Farmavita Net is professional community and network of pharmaceutical licensing and business development executives, innovators and researchers
Farmavita.Net is the pharmaceutical licensing, technology transfer and regulatory affairs network. We are managing the marketplace of offers and demand for pharmaceutical Dossiers, know-how and technologies. Members of Farmavita.Net network usually find a number of attractive solutions for business development, alliances, joint ventures, co-development and co-marketing of pharmaceutical products. Farmavita.Net is not just a pure Internet portal. We manage a number of regional associates. We are connecting the dynamic network of few hundreds members / pharmaceutical companies interested in license-in and license-out opportunities.



Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!



CanBiotech - A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Outsourcing Services Showcase; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the BioMedical Outsourcing Report and the Bio Outsourcing Asia© Publication.



LabRoots is a free, social networking site that enables scientists, engineers, and other technical professionals to connect, collaborate with, and learn from each other. LabRoots fosters world-wide scientific communication and incorporates the newest social networking technologies. LabRoots allows scientists to connect with each other as they describe their research interests on a myriad of unique features and tools, discovering meaningful collaborations across geographic boundaries and fields of expertise.

Bentham Science


Bentham Science Publishers is a major STM journal publisher of 130 plus print and online journal. Out of these, 40 journals have already registered good IMPACT FACTORS as per Journal Citation Reports® 2017. These titles have extensive readership mostly in Europe and North America. For a detailed profile please visit our website at http://www.benthamscience.com. Besides, Bentham Science publishes eBooks in all areas of Science, Technology and Medicine. Our eBooks provide professionals, academicians, corporate researchers, graduates and undergraduates worldwide with the most current information in their subject areas of interest. Our eBooks are also available in the ePub and Kindle formats besides the PDF edition here http://ebooks.benthamscience.com/. Bentham is offering attendees of this conference discounts on its publication. For more information click here

Bioportfolio Limited


BioPortfolio.com is a leading news, information and knowledge resource covering the global life science industries impacted by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to source core information on specific bio-related topics, to collate relevant data associated with each topic and to point the user to relevant knowledge resources

American Pharmaceutical Review


Start receiving your free copy today. American Pharmaceutical Review is a review of the drug pipeline from the late discovery phase through manufacturing. American Pharmaceutical Review prides itself on having the most relevant, unbiased and informative editorial in the industry. You will find that all of our editorial is highly technical and written by government agencies, consultants, academics, and large pharmaceuticals companies. American Pharmaceutical Review covers several key topics that are important to drug production:Separations and purification, Drug Delivery, Biopharmaceutical Processing, Biopharmaceutical Development, Formulation development, Manufacturing, Microbiology, Instrumentation, Spectroscopy

Cutting Edge


Cutting Edge Information provides customized research and benchmarking reports to pharmaceutical, biotechnology and other life science companies. We provide off-the-shelf and customized research for key areas including medical affairs, clinical development, market access, regulatory affairs, marketing management, sales and HCP fair market value.



Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/

One Nucleus


Established in May 2010, One Nucleus is the result of the merger of ERBI and London Biotechnology Network. One Nucleus is a not-for-profit membership organisation for international life science and healthcare companies and the largest of its kind in Europe. The company is based in Cambridge UK and London, at the heart of Europe's largest cluster. The 470 members include pharmaceutical, biotech, medical device and diagnostic companies and associated technical and commercial Service Providers.

Antibodies Online


antibodies-online.com facilitates researchers to find the appropriate antibodies for their respective research project. As an independent and multi-vendor marketplace for research antibodies and thanks to the cooperation with more than 130 different manufacturers, a large selection of Antibodies (over 700,000), ELISA Kits (over 130,000), Secondary Antibodies (17,000), Proteins (130,000), Peptides and Isotype Controls is available. By supporting the Independent Validation Initiative and the Resource Identification Initiative, antibodies-online.com also addresses the important topics of transparent product quality and scientific reproducibility. In addition scientists receive news and detailed information about the individual antibodies from databases such as the PubMed and others.

Pharmaceutical Technology


Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.

Technology Networks


Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com



Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.



MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com

The Pharma Letter


The Pharma Letter provides subscribers with daily, up-to-date news, business intelligence, comment and analysis for the pharmaceutical, biotechnology and generics sectors of the health care industry, backed by a team of respected writers with many years of experience in the field.



Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc.

Drug Discovery Today


Drug Discovery Today is one of the most cited review journals in the field of drug discovery, with an impact factor of 6.422.
Drug Discovery Today will benefit your research by helping to keep you up-to-date with all of the fast-moving and emerging topics in drug discovery. Each issue is packed full of the latest research news, peer-reviewed articles and comment and opinion from leading research scientists.



Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.

International Pharmaceutical Industry


IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. IPI provides a proven supportive means of communication to the Pharmaceutical, Bio Pharmaceutical, Nutraceutical and Medical Devices industry, incorporating the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies.



GBI is an information, applications, and services company focused on the healthcare industry. Leveraging data from across the healthcare value chain, GBI creates web and mobile applications that enable individuals and organizations to make better decisions and communicate more effectively.



www.PharmCast.com is the world leading website designed specifically for pharmaceutical, clinical and biotechnology professionals. www.PharmCast.com brings up-to-date information on pharmaceutical patents, FDA, news, jobs and Buyer's Guide to our visitors. It was created and is maintained by pharmaceutical and biotechnology professionals. Visit www.PharmCast.com and discover for yourself why it is so popular among professionals.



PMR (www.pmrcorporate.com) is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern European countries as well as other emerging markets. PMR's key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research ). Being present on the market since 1995, offering high international standards in projects and publications, as well as providing one of the most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.

Contract Biotechnology


Contract-Biotechnology.com is a web-based platform for laboratory outsourcing solutions. We are an online R&D matching tool that connects Scientifics and organizations involved in discovery, development and delivery of new healthcare products with service and products providers worldwide. Life science information technology is undergoing a revolution. Part of that revolution involves new, unexplored business models, open innovation, open data and collaboration. If you have a project or idea that you would like to propose, develop or run, we can help. A New Collaboration Network Model for Discovery Research and Development • Effective Platform: the 95% • 5.000 registered users // > 15.000 Newsletter subscribers • Geographical background: 45,5% Europe / 37,5% North America / 16,5% Asia / 0,5% ROW • Professional background: Outsourcing Manager, Project Manager, CEO, Business Developer, CSO, Account Manager, Sales & Marketing People, Scientists, R&D. For further information, please visit our website www.contract-biotechnology.com



pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com





Established in October 2003, PharmiWeb Solutions is an energetic, innovative provider of web-based solutions for the pharmaceutical sector, with customers such as AstraZeneca, Roche, Servier Laboratories, and Merck With solutions in three key areas: Online Publishing, e-Business and Mobile Computing, we deliver connectivity – between people and applications – unlocking islands of data and knowledge. We own some of the sector’s most innovative Online Publications: PharmiWeb.com, HospitalPharma.com and Detail-Direct.com. We are actively developing solutions for Mobile Computing platforms. For example, our PharmiTabTM e-pharmacy solution runs real-time patient data and prescribing transactions in a busy hospital environment, on a TabletPC, wireless client/server platform. e-Business solutions range from e-Detailing, to Online Market Research, all designed to increase reach, increase sales, and to reduce administration and costs.

British Pharmacological Society


The British Pharmacological Society (BPS) is the primary UK learned society concerned with research into drugs and the way they work. Our members work in academia, industry, regulatory agencies and the health services, and many are medically qualified. The Society covers the whole spectrum of pharmacology, including laboratory, clinical, and toxicological aspects. Clinical pharmacology is the medical speciality dedicated to promoting safe and effective use of medicines for patient benefit. Clinical pharmacologists work as consultants in the NHS and many hold prominent positions in UK Universities.

Pharmaceutical Online


The premier sourcing site for the pharmaceutical manufacturing industry – find industry information on critical environment, particle sizing, pharma process control, pharma material handling, tablet production, pharma sterilizing, pharma cleaning, pharma filtration, pharma packaging, pharma inspection, & much more. Use our supplier directory, product showcase, and offline search service to expedite your discovery of new products and services.

Drug Development Technology


Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.

Lab Bulletin


Lab Bulletin is a free online resource for scientists and laboratory professionals where you can catch up on the latest news for laboratory products and services. You will find an extensive directory of laboratory suppliers and manufacturers enabling you to contact companies quickly and easily to request further information. Lab Bulletin also publishes four free monthly E-Newsletters keeping you up-to-date with all of the latest laboratory products and industry news directly to your inbox. We have dedicated E-Newsletters for Chromatography and Spectroscopy, Microscopy and Image Analysis, weekly Industry News updates and our monthly Lab Bulletin E-Newsletter sent out to over 29,000 readers worldwide. To request your free copy click here



PharmaVOICE magazine, and its supporting VIEW publications, provide commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE's more than 41,000 U.S.-based subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers.

Marriott Regents Park

128 King Henry's Road
London NW3 3ST
United Kingdom

Marriott Regents Park

This 4 star north London hotel in zone 2 is the perfect destination for the astute business traveler as well as the leisure guest that knows how convenient north London hotels are, as a base from which to explore the city .Bond Street is just 3 stops from Swiss Cottage underground station on the Jubilee Line, so you can be shopping, exploring the sights and taking in one of London’s world-renowned West End shows in less than 15 minutes when you stay at this hotel near central London. At the same time, the hive of activity that is Camden Town, the chic shops, cafes and restaurants of Primrose Hill and ZSL’s London Zoo in Regents Park are all just a short walk from this hotel in north London.



speaker image






CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.


There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.


Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.


Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

CPD Certificates

We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

Event Title


Read More

I would like to speak at an event

I would like to attend an event

I would like to sponsor/exhibit at an event


Sign up
Forgotten Password?


UK Office
Opening Hours: 9.00 - 17.30 (local time)
SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
Registered in England No: 3779287 VAT No: GB 976 2951 71

Forgotten Password

Please enter the email address you registered with. We will email you a new password.

Thank you for visiting our event

If you would like to receive further information about our events, please fill out the information below.

By ticking above you are consenting to receive information by email from SMi.
Full details of our privacy policy can be found here https://www.smi-online.co.uk/privacy-legals/privacy-policy/.
Should you wish to update your contact preferences at any time you can contact us at data@smi-online.co.uk.
Should you wish to be removed from any future mailing lists please click on the following link http://www.smi-online.co.uk/opt-out